Description and Brand Names
Drug information provided by: IBM Micromedex
US Brand Name
- Dengvaxia
Descriptions
Dengue tetravalent vaccine, live is used to prevent dengue disease in children 9 to 16 years of age with a previous laboratory-confirmed dengue infection and who are living in endemic (where the disease is common) areas.
This vaccine is to be given only by or under the direct supervision of your doctor.
Portions of this document last updated: Oct. 01, 2020
Copyright © 2020 IBM Watson Health. All rights reserved. Information is for End User's use only and may not be sold, redistributed or otherwise used for commercial purposes.